TABITHA CLEMONS: Open Payments
NPI 1831309509 · MUSCLE SHOALS, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,035 in 59 payments from 13 companies in 2025. Trend: 2023 $616 · 2024 $619 · 2025 $1,035
Food & beverage: $1,035
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 17 | $236 |
| AstraZeneca Pharmaceuticals LP | 8 | $171 |
| PFIZER INC. | 6 | $101 |
| Lilly USA, LLC | 5 | $96 |
| Exact Sciences Corporation | 4 | $81 |
| Phathom Pharmaceuticals, Inc. | 4 | $70 |
| Amgen Inc. | 4 | $64 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $62 |
| Astellas Pharma US Inc | 2 | $49 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $31 |
Products named: Ozempic, Wegovy, BREZTRI, Cologuard Collection Kit, ELIQUIS, MOUNJARO, VOQUEZNA, CAPLYTA.
Industry payments across AL — which companies pay providers there.
